Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Two Cases of Retroperitoneal Synovial Sarcoma].
Saito Y, Shindo T, Kobayashi K, Hashimoto K, Kyoda Y, Maehana T, Tanaka T, Arihara Y, Murase K, Takada K, Masumori N. Saito Y, et al. Among authors: tanaka t. Hinyokika Kiyo. 2024 Jan;70(1):1-5. doi: 10.14989/ActaUrolJap_70_1_1. Hinyokika Kiyo. 2024. PMID: 38321742 Japanese.
Efficacy and safety of desmopressin orally disintegrating tablets 25 and 50 μg in male patients with nocturia: A Japanese real-world multicenter clinical study.
Kyoda Y, Kimura M, Shimizu T, Miyao N, Ogasawara T, Shimizu T, Iwasawa A, Yorozuya W, Hashimoto J, Ichihara K, Takei F, Uchida K, Kouzen N, Suzuki N, Tachikawa K, Shibuya A, Muranaka I, Okada M, Igarashi M, Shibamori K, Nofuji S, Fujino K, Toyota T, Ito Y, Shinkai N, Hashimoto K, Kobayashi K, Tanaka T, Masumori N. Kyoda Y, et al. Among authors: tanaka t. Low Urin Tract Symptoms. 2022 Nov;14(6):410-415. doi: 10.1111/luts.12459. Epub 2022 Aug 5. Low Urin Tract Symptoms. 2022. PMID: 36319193
Efficacy of cognitive behavioral therapy using self-check sheet for patients with nocturia in real-world clinical practice.
Kyoda Y, Ichihara K, Muranaka I, Sakai Y, Nakamura M, Shinkai N, Kozen N, Yorozuya W, Morooka D, Maruo K, Tachikawa K, Shibamori K, Nofuji S, Fujino K, Kato S, Yoshida T, Shindo T, Maehana T, Hashimoto K, Kobayashi K, Tanaka T, Masumori N. Kyoda Y, et al. Among authors: tanaka t. Low Urin Tract Symptoms. 2023 Nov;15(6):225-230. doi: 10.1111/luts.12498. Epub 2023 Aug 23. Low Urin Tract Symptoms. 2023. PMID: 37614063 Clinical Trial.
Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy.
Okada M, Shindo T, Fujino K, Maeda T, Ito N, Takahashi A, Hotta H, Kunishima Y, Matsukawa M, Takayanagi A, Wanifuchi A, Nofuji S, Kato R, Fukuta F, Hashimoto K, Kobayashi K, Tanaka T, Masumori N. Okada M, et al. Among authors: tanaka t. Support Care Cancer. 2023 Oct 3;31(10):607. doi: 10.1007/s00520-023-08087-6. Support Care Cancer. 2023. PMID: 37787829
Surgical strategy for orthotopic kidney transplantation.
Hotta K, Miura M, Tanaka T, Tanabe T, Masumori N, Shinohara N. Hotta K, et al. Among authors: tanaka t. Int J Urol. 2024 May;31(5):582-584. doi: 10.1111/iju.15418. Epub 2024 Jan 31. Int J Urol. 2024. PMID: 38297483 No abstract available.
Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy.
Shindo T, Hashimoto K, Takahashi A, Miyamoto S, Kunishima Y, Sato S, Fukuta F, Hiyama Y, Takayanagi A, Kato R, Wanifuchi A, Ueki Y, Okada M, Adachi H, Kobayashi KO, Tanaka T, Masumori N; Sapporo Medical University Urologic Oncology Consortium. Shindo T, et al. Among authors: tanaka t. Anticancer Res. 2024 Mar;44(3):1271-1279. doi: 10.21873/anticanres.16922. Anticancer Res. 2024. PMID: 38423657
17,368 results
You have reached the last available page of results. Please see the User Guide for more information.